PERSPECTA

News from every angle

← Back to headlines

H.C. Wainwright Initiates Coverage of Generate Biomedicines

H.C. Wainwright has initiated coverage of Generate Biomedicines (GENB) with a 'Buy' rating. This new analyst report offers a positive investment perspective on the biotechnology firm.

20 Apr, 00:11 — 20 Apr, 00:11
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual142d ago

H.C. Wainwright Initiates Coverage of Generate Biomedicines (GENB) With a Buy Rating

Read full article →

Related Stories

Scientists Warn Very Hot Drinks May Increase Esophageal Cancer Risk

1h ago

Greek Artist Giorgos Mazonakis Dies After Hospital Struggle

2h ago

Bangladesh Measles Outbreak Kills Over 1,000 Children

4h ago

Greek Woman Gives Birth from Embryo Frozen for 22 Years

4h ago